Synthesis, evaluation and docking studies on steroidal pyrazolones as anticancer and antimicrobial agents

Medicinal Chemistry Research

Volumn 23, Issue 1, 2014, Pages 348-362

  Shamsuzzaman, S ^a   Mashrai, Ashraf ^a   Ahmad, Anis ^a   Dar, Ayaz Mahmood ^a   Khanam, Hena ^a   Danishuddin, Mohd ^a   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Anticancer; Antimicrobial; Docking; Pyrazolone; Steroid

Indexed keywords

EID: 84893680300     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0636-y     Document Type: Article

References (57)

1. Al-Haiza MA, El-Assiery SA, Sayed GH (2001) Synthesis and potential antimicrobial activity of some new compounds containing the pyrazol-3-one moiety. Acta Pharm 51:251-261
2. Andrasi M, Buglyo P, Zekany L, Gaspar A (2007) A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants. J Pharm Biomed Anal 44:1040-1047
3. Atta UR, Anjum S, Farooq A, Khan MR, Parveen Z, Choudhary MI (1998) Antibacterial steroidal alkaloids from Sarcococca saligna. J Nat Prod 61:202-206
4. Bansal R, Guleria S (2008) Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy) benzylidene] androstene derivatives as potent cytotoxic agents. Steroids 73:1391-1399
5. Bhandarkar MR, Khan A (2004) Antihepatotoxic effect of Nymphaea stellata willd., against carbon tetrachloride-induced hepatic damage in albino rats. J Ethnopharmacol 91:61-64
6. Bondock S, Tarhoni A El-G, Fadda A A (2006) Utility of cyanoacetic acid hydrazide in heterocyclic synthesis. ARKIVOC (ix) 113-156
7. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy minimization and dynamics calculations. J Comp Chem 4:187-217
8. Callow RK, James VHT (1956) By-ways of synthesis of cortisone from hecogenin. Part II. A route to 11-oxygenated compounds through 3β: 20β-diacetoxy-11-bromoallopregnan-12-one. J Chem Soc 4744-4749
9. Carvalho JFS, Silva MMC, Moreira JN, Simoes S, Melo MLS (2010) Sterols as anticancer agents: synthesis of ring-B oxygenated steroids, cytotoxic profile, and comprehensive SAR analysis. J Med Chem 53:7632-7638
10. Cerda S, Wilkinson J, Broitman S (1995) Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines. Lipids 30:1083-1092
11. Dauben GW, Takemura KH (1953) A study of the mechanism of conversion of acetate to cholesterol via squalene. J Am Chem Soc 75:6302-6304
12. Djouhri-Bouktab L, Vidal N, Rolain JM, Brunel JM (2011) Synthesis of new 3, 20 bispolyaminosteroid squalamine analogues and evaluation of their antimicrobial activities. J Med Chem 54:7417-7421
13. Gerweck LE, Vijayappa S, Kozin S (2006) Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 5:1275-1279
14. 17α. J Org Chem 64:4985-4989
15. Handratta VD, Vasaitis TS, Njar VCO, Gediya LK, Kataria R, Chopra P, Newman D Jr, Farquhar R, Guo Z, Qiu Y, Brodie AMH (2005) Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model. J Med Chem 48:2972-2984
16. Hansch C, Fujita T (1964) p-σ-π analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 86:1616-1626
17. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, Ebner H, Ebner C (2003) IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 111:882-888
18. Ikonen E (2008) Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 9:125-138
19. Jayasinghe UL, Nadeem M, Atta R, Choudhary MI, Ratnayake HD, Amtul Z (1998) New antibacterial steroidal alkaloids from Sarcococca brevifolia. Nat Prod Lett 12:103-109
20. Ji H, Zhang W, Zhang M, Kudo M, Aoyama Y, Yoshida Y, Sheng C, Song Y, Yang S, Zhou Y, Lu J, Zhu J (2003) Structure based de novo design, synthesis, and biological evaluation of nonazole inhibitors specific for lanosterol 14R-demethylase of fungi. J Med Chem 46:474-485
21. Jones G, Willett P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245:43-53
22. Kaminskyy D, Bednarczyk-Cwynar B, Vasylenko O, Kazakova O, Zimenkovsky B, Zaprutko L, Lesyk R (2012) Synthesis of new potential anticancer agents based on 4-thiazolidinone and oleanane scaffolds. Med Chem Res 21:3568-3580
23. Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito KI (1997) Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 281:921-927
24. Koutsourea AI, Fousteris MA, Arsenou ES, Papageorgiou A, Pairas GN, Nikolaropoulos SS (2008) Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters. Bioorg Med Chem 16:5207-5215
25. Krstic'a NM, Bjelakovic′ MS, Zizˇakb Z, Pavlovic MD NM, Juranic′ ZD, Pavlovic′ VD (2007) Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities. Steroids 72:406-414
26. Lagunin A, Filimonov DA, Borodina YV, Lagunin AA, Kos A (2010) Multitargeted natural products evaluation based on biological activity prediction with PASS. Cur pharm des 16:1703-1717
27. 17α. J Med Chem 40:3297-3304
28. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23:3-25
29. Massey JB, Pownall HJ (2006) Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry 45:10747-10758
30. Millurn AH, Truter EV (1956) The components of wool wax. Part III. 7-Oxocholesterol and the alleged presence of cholestanol. J Chem Soc 341:1736-1739
31. Moreau F, Desroy N, Genevard JM, Vongsouthi V, Gerusz V, Fralliec GL, Oliveira C, Floquet S, Denis A, Escaich S, Wolf K, Busemann M, Aschenbsenner A (2008) Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors. Bioorg Med Chem Lett 18:4022-4026
32. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
33. Muegge I (2003) Selection criteria for drug-like compounds. Med Res Rev 23:302-321
34. Nikaido H (1996) Outer Membrane in Escherichia coli and Salmonella. In: Neidhardt FC, Curtis R III, Ingraham JL (eds) Cellular and molecular biology. ASM, Washington, DC, pp 29-47
35. Pan Y, Cai B, Wang K, Wang S, Zhou S, Yu X, Xu B, Chen L (2009) Neferine enhances insulin sensitivity in insulin resistant rats. J Ethnopharmacol 124:98-102
36. Pasha FA, Muddassar M, Neaz MM, Cho SJ (2009) Pharmacophore and docking-based combined in silico study of KDR inhibitors. J Mol Graph Model 28:54-61
37. Poza J, Rega M, Paz V, Alonso B, RodrI'guez J, Salvador N, Ferna'ndez A, Jime'nez C (2007) Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents. Bioorg Med Chem 15:4722-4740
38. Refsgaard HH, Jensen BF, Brockhoff PB, Padkjaer SB, Guldbrandt M, Christensen MS (2005) In silico prediction of membrane permeability from calculated molecular parameters. J Med Chem 48:805-811
39. Roy J, DeRoy P, Poirier D (2007) 2β-(N-substituted piperazino)- 5α-androstane-3α17β-diols: parallel solid-phase synthesis and antiproliferative activity on human leukemia HL-60 cells. J Comb Chem 9:347-358
40. Salvador JAR, Carvalho JFS, Neves MAC, Silvestre SM, Leitào AJ, Silva MMC, Melo MLS′ (2013) Anticancer steroids: linking natural and semi-synthetic compounds. Nat Prod Rep 30:324-374
41. Saxena HO, Faridi U, Kumar JK, Luqman S, Darokar MP, Shanker K, Chanotiya CS, Gupta MM, Negi AS (2007) Synthesis of chalcone derivatives on steroidal framework and their anticancer activities. Steroids 72:892-900
42. Seong BC, Yon K, Yun MY, Byung ZA (2004) 5-Arylidene-2(5H)-Furanone derivatives: synthesis and structure-activity relationship for cytotoxicity. Arch Pharm Res 5:485-494
43. Shamsuzzaman, Khan MS, Alam M, Tabassum Z, Ahmad A, Khan AU (2010) Synthesis, antibacterial and antifungal activities of 6, 5 fused steroidal oxazoles in cholestane series. Eur J Med Chem 45:1094-1097
44. Shamsuzzaman, Khanam H, Dar AM, Siddiqui N, Rehman S (2012) Synthesis, characterization, antimicrobial and anticancer studies of steroidal pyrazolines. J Saudi Chem Soc. doi: 10.1016/j.jscs.2012.05.004
45. Shamsuzzaman, Khanam H, Mashrai A, Siddiqui N (2013) Construction of novel steroidal isoxazolidinone derivatives under Vilsmeier-Haack conditions. Tetrahedron Lett 54:874-877
46. Slater TF, Swyer B, Strauli U (1963) Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 77:383-393
47. Tabas I (2002) Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110:905-911
48. Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, Murakami T (1998) Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur J Pharmacol 358:289-294
49. Thibeault D, Roy J, Roy PD, Poirier D (2008) Chemical synthesis of 2βamino-5 α- androstane-3α17 β-diol N-derivatives and their antiproliferative effect on HL-60 human leukemia cells. Bioorg Med Chem 16:5062-5077
50. Uetrecht J (2001) Prediction of a new drug's potential to cause idiosyncratic reactions. Curr Opin Drug Discov Devel 4:55-59
51. Vaara M (1993) Outer membrane permeability barrier to azithromycin, clarithromycin in Gram-negative enteric bacteria. Antimicrob Agents Chemother 37:354-356
52. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kapple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615-2623
53. Vejux A, Lizard G (2009) Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 30:153-170
54. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127-134
55. Wani MY, Athar F, Salauddin A, Agarwal SM, Azam A, Choi I, Bhat AR (2011) Novel terpene based 1,4,2-dioxazoles: synthesis, characterization, molecular properties and screening against Entamoeba histolytica. Eur J Med Chem 46:4742-4752
56. Woerdenbag HJ, Moskal TA, Pras N, Malingre TM, El-Feraly FS, Kampinga HH, Konings AWT (1993) Cytotoxicity of artemisinin-related endoperoxides to ehrlich ascites tumor-cells. J Nat Prod 56:849-856
57. Wu TW, Zeng LH, Wu J, Fung KP (2002) Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sci 71:2249-2255